Part 1: The Impact of COVID Vaccines and Variants
Watch part one of a two-part series covering topics that will have a significant impact on your business in 2022
There is reason to be optimistic that COVID will have a less direct impact on U.S. companies in the next year. But, the Delta and Omicron variants have proven that this global pandemic is far from over. As countries worldwide continue to struggle with COVID-related challenges, it will create new sets of economic issues that can have significant implications for U.S.-based companies throughout 2022.
In this on-demand micro-webinar, Prevedere senior economist Boyd Nash-Stacey discusses how COVID will impact American businesses in 2022 and provides key insights for executives when planning for potential outcomes.
- The current state of COVID in the United States
- The potential impact of COVID variants on U.S. Companies in 2022
- Building forecasts and business plans to account for possible scenarios that will impact your business
***
About Prevedere, Inc.
Prevedere is the world’s leading provider of predictive analytics technology and solutions based on econometric modeling, enabling intelligent enterprises to understand and quantify the impact of external factors as part of their strategic planning and forecasting. Our global data repository and patented AI platform enable financial executives and operational planners to identify market drivers, quantify the future impact of economic volatility, generate performance forecasts, and optimize plans based on market foresight.
Prevedere’s automated AI model monitoring provides an early warning system when unplanned market shifts and anomalies are predicted, enabling planners to future proof business performance. Many of the world’s leading consumer packaged goods, retail, logistics, and manufacturing companies leverage Prevedere to generate economic intelligence, spot market opportunities, mitigate risks, and deliver exclusive competitive advantage.